Lunai Bioworks LNAI
NASDAQ LNAI
$0.29 -0.18 (-38.30%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Sale and Maturity of Investments (2025)

Updated

Lunai Bioworks (LNAI) reported Sale and Maturity of Investments - Total of $544,700 for fiscal Q1 2026 (quarter ended Sep 30, 2025).

Analysis

Lunai Bioworks (LNAI) Sale and Maturity of Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Lunai Bioworks 974,661.84 974,661.84 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 544,700.00
API Access

Lunai Bioworks Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LNAI&period=max&api_key=YOUR_API_KEY